Volume 10
Issue 1 January

Article 3

The Long-term Clinical Prognosis in Patients with Anterior Wall and Nonanterior Wall Acute Myocardial Infarction Referred to Primary Percutaneous
Transluminal Coronary Angioplasty
Mingzhong Zhao
Dayi Hu
Tianchang Li
Sanqing Jia

Follow this and additional works at: https://www.jhkcc.com.hk/journal
Part of the Cardiology Commons, Cardiovascular Diseases Commons, and the Medical Education Commons

Recommended Citation
Mingzhong Zhao, Dayi Hu, Tianchang Li, Sanqing Jia, The Long-term Clinical Prognosis in Patients with Anterior Wall
and Non-anterior Wall Acute Myocardial Infarction Referred to Primary Percutaneous Transluminal Coronary
Angioplasty Journal of the Hong Kong College of Cardiology 2002;10(1) https://doi.org/10.55503/2790-6744.1183
This Original Article is brought to you for free and open access by Journal of the Hong Kong College of Cardiology. It has been
accepted for inclusion in Journal of the Hong Kong College of Cardiology by an authorized editor of Journal of the Hong Kong
College of Cardiology.

The Long-term Clinical Prognosis in Patients with Anterior Wall and
Non-anterior Wall Acute Myocardial Infarction Referred to Primary
Percutaneous Transluminal Coronary Angioplasty
MINGZHONG ZHAO, DAYI HU, TIANCHANG LI, SANQING JIA, MING YANG, YUYUN XU
From Department of Cardiology, People's Hospital, Beijing University, Beijing 100044, China
ZHAO ET AL.: The Long-term Clinical Prognosis in Patients with Anterior Wall and Non-anterior Wall Acute
Myocardial Infarction Referred to Primary Percutaneous Transluminal Coronary Angioplasty. Objective: To
investigate the long-term clinical prognosis in patients with anterior wall acute myocardial infarction (AW-AMI)
and non AW-AMI (NAW-AMI) referred to primary percutaneous transluminal coronary angioplasty (P-PTCA).
Methods: 287 patients with AMI who underwent P-PTCA were divided into AW-AMI group (142 cases) and NAWAMI group (145 cases) according to different sites of AMI. The baseline characteristics and coronary artery lesions
of patients were analysed. The primary end points were in-hospital mortality and the major cardiovascular events
(MACE) during a mean 17.3±9.8 months follow-up including the occurrences of non-fatal myocardial infarction,
non-fatal congestive heart failure, revascularization of target vessels and overall cardiac-related death. Results:
The peak values of CK and CK-MB were significantly higher (3533±2888 U/L vs 2322±1638 U/L, 158±197 U/L vs
95±64 U/L, all P<0.01), and left ventricular ejection fraction decreased (0.55±0.13 vs 0.61±0.12, P<0.05) and inhospital mortality increased significantly (4.1% vs 0, P<0.05) in AW-AMI group than in NAW-AMI group. At a
follow-up of mean 17.3±9.8 months, the incidences of non-fatal heart failure, in-hospital mortality, total cardiacrelated mortality and combined end points in AW-AMI group increased significantly than those in NAW-AMI group
(all P<0.05). Multivariate analysis revealed that anterior location of myocardial infarction and proximal left anterior
descending (LAD) coronary artery lesion were associated with the occurrence of cardiac-related death in patients
with AMI after procedure of PTCA (all P<0.05). Conclusions: The present study shows that anterior location of
myocardial infarction is associated with a higher incidence of MACE. The long-term clinical outcomes are poorer in
patients with AW-AMI than NAW-AMI referred to P-PTCA. (J HK Coll Cardiol 2002;10:3-6)
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Introduction
During the treatment of acute myocardial
infarction (AMI), early and effective recanalization of
infarct-related artery (IRA) is a very important strategy.
Primary percutaneous transluminal coronary
angioplasty (P-PTCA) or intracoronary stenting can
restore immediate TIMI 3 coronary flow of IRA. A few
reports showed the advantages of P-PTCA over
intravenous thrombolysis in the treatment of AMI. But,
the different sites of myocardial infarction might affect
the patients' clinical outcomes. The risk of patients with
anterior wall AMI (AW-AMI) was higher than that of
patients with non-anterior wall AMI (NAW-AMI)
because of their greater myocardial infarction sizes.1 In
the present study, we investigated the effect of P-PTCA
on the long-term clinical outcomes in patients with AWAMI and NAW-AMI.

included 142 cases (male:110 cases and female:32
cases) and the latter group included 145 cases (male:
103 cases and female:42 cases).

Angiography and PTCA
AMI patients were sent directly to catheterization
laboratory from Emergency Department. At first, CAG
was performed with Judkins method, then primary
PTCA or intracoronary stenting was decided according
to the characteristics of coronary artery disease.
Generally, we usually intervened with IRA during
emergency procedure.

Follow-up
Patients were followed up within 1 to 41 months
(a mean 17.3±9.8 months) for in-hospital mortality and
major cardiovascular events (MACE), which included
incidences of non-fatal myocardial infarction, non-fatal
heart failure, need for target vessel revascularization
(TVR) and total cardiac mortality.

Methods
Statistical Analysis
Patient Population
From January 1997 to December 2000, a total of
287 patients had taken emergency coronary artery
angiography (CAG) at our hospital with AMI and
suitable coronary anatomy for P-PTCA. The eligibility
criteria of P-PTCA were documented by the following:
(1) Persistent chest pain ≥30 min, with no relief by
nitrates; (2) ECG showing 1 mm ST segment elevation
in two contiguous limb leads or 2 mm ST segment
elevation in two contiguous precordial leads; (3) Fewer
than 12 hours from onset of symptoms; (4) AMI patients
with recurrent ischemic symptoms or persistent ST
segment elevation or CAG showing TIMI 0-II flow at
90 min after thrombolysis should undergo rescue PTCA.
For patients meeting above criteria, written informed
consents were obtained before they underwent PTCA
in the catheterization laboratory.
According to the presentation of electrocardiogram (ECG), AMI patients were divided into AWAMI and NAW-AMI groups. The former group
4

Continuous variables are expressed as mean±s;
discrete variables are expressed as percentages.
Differences between two groups were evaluated with
the student t test or χ2 test. The logistic regression
analysis was used to investigate the changes of risk
factors of cardiac death.

Results
Baseline Clinical and Angiographic
Characteristics (Table 1)
The results showed the percentages of patients
with angina before AMI or with Killip class II-IV, and
the peak values of CK or CK-MB were higher in AWAMI group than in NAW-AMI group (P<0.01).
Angiogram indicated that left anterior descending (LAD)
was the dominant IRA of patients with AW-AMI and
right coronary artery (RCA) was the dominant IRA of
patients with NAW-AMI.
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Discussion

The Results of Follow-up (MACE)
Stent was implanted in 91.6% and 86.9% of AWAMI and NAW-AMI patients respectively (P>0.05). Out
of 287 patients, 122 patients with AW-AMI and 117
patients with NAW-AMI were followed up. The
incidences of non-fatal heart failure, in-hospital
mortality, total cardiac death and combined end points
were significantly higher in the AW-AMI group than in
the NAW-AMI group (Table 2).

The Effect of IRA on Cardiac Death Rate (Table 3)
The mortality rate was higher in patients whose
IRA were left main trunk (LMT) than those whose IRA
were LAD, LCX or RCA. Proximal and non-proximal
lesions in IRA were identified according to the different
sites of coronary occlusion.2 Compared with patients
with non-proximal IRA lesions, the cardiac mortality
was higher in patients with proximal IRA lesions in LAD
(P<0.05).
Logistic regression analysis revealed that
myocardial infarction sites (anterior wall) and proximal
LAD lesion were associated with the occurrence of
cardiac-related death in patients with AMI after PTCA
procedure (all P<0.05).

This report described that the enzyme leak, the
Killip Class and left ventricular ejection were poorer in
patients with AW-AMI than NAW-AMI. More patients
with angina before AMI were presented in the AW-AMI
group. The increased risk of patients with anterior wall
AMI was associated with greater myocardial necrosis,
as well as larger infarct expansion, which resulted in
aneurysm formation, heart failure, mural thrombus
formation and myocardial rupture.3-5 CAG showed no
difference between the 2 groups besides IRA. LAD was
the dominant IRA in AW-AMI group, and RCA was
the dominant IRA in NAW-AMI group. It was reported
that AMI patients by occlusion of LAD had a higher
risk and more importantly clinical significance than
those by occlusion of LCX or RCA.6
The follow up data in this study showed that
although there was no significant difference in rates of
non-fatal myocardial infarction and TVR between the 2
groups, the incidences of non-fatal heart failure, inhospital mortality and total cardiac mortality increased
significantly in the AW-AMI group. The combined end
point event was also higher in the AW-AMI group than

Table 1. Baseline clinical and angiographic characteristics
Characteristics
Age
Hypertension
Hyperlipideremia
Diabetes
Smoking
Angina before AMI
Killip class II-IV
Duration from onset of symptom to reperfusion (min)
Rescue-PTCA
CK (U/L)
CK-MB (U/L)
LVEF
Single vessel disease
Multivessel disease
LM
Infarct-related artery (IRA)
LAD
LCX
RCA
LM

AW-AMI group (142)
63.2±8.9
35.9 (51/142)
26.8 (38/142)
11.3 (16/142)
38.0 (54/142)
59.9** (85/142)
28.8** (41/142)
251±154
11.3 (16/142)
3533±2888**
158±197**
0.55±0.13*
52.8 (75/142)
47.2 (67/142)
6.3 (9/142)

NAW-AMI group (145)
62.1±9.5
29.0 (42/145)
22.1 (32/145)
11.0 (16/145)
45.5 (66/145)
35.2 (51/145)
10.0 (15/145)
268±141
9.0 (13/145)
2322±1638
95±64
0.61±0.12
41.4 (60/145)
58.6 (85/145)
5.5 (8/145)

95.8** (136/142)
0**
1.4** (2/142)
2.8 (4/142)

2.8 (4/145)
20.7 (30/145)
76.5 (111/145)
0

LVEF, left ventricular ejection fraction; LM, left main; LAD, left anterior descending
*P<0.05, **P<0.01, patients with AW-AMI versus with NAW-AMI
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Table 2. The incidence of MACE in the two groups
MACE

AW-AMI (n=122)
case
%
2
1.6
18
14.8*
9
7.4
5
4.1*
8
6.6*
37
30.3*

Non-fatal myocardial infarction
Non-fatal heart failure
Target vessel revascularization
In-hospital mortality
Total cardiac death rate
Combine end points

NAW-AMI (n=117)
cases
%
1
0.9
8
6.8
10
8.6
0
0
2
1.7
21
18.0

*P<0.05, patients with AW-AMI versus with NAW-AMI

Table 3. The effect of IRA on cardiac death rate
IRA

Cases

LAD
proximal
non-proximal
LCX
proximal
non-proximal
RCA
proximal
non-proximal
LM
proximal
non-proximal

112
54
58
30

Cardiac mortality
cases
%
7
6.3*
6
11.1c
1
1.7
0**

References

21
9
93
57
36
4
1
3

2
1
1
1
1
0

2.2**
1.8
2.8
25.0
100

*P<0.05,**P<0.01, compared with patients whose IRA are LM;
cP<0.05, compared with non-proximal at the same vessel

the NAW-AMI group. Furthermore, our study also
showed the cardiac mortality rate was higher in patients
whose IRA was LMT or proximal in LAD compared
with other subgroups, but it should be further studied
due to limited cases. The present study indicated that
patients with AW-AMI was a high risk population, which
was identical to the results that Zijlstra reported.7 The
patients with AW-AMI were likely to have a greater
likelihood of a cardiac event at follow-up than NAWAMI. 8 The multivariate analysis revealed that
myocardial infarction sites (anterior wall) and proximal
LAD lesion were associated with the occurrence of
cardiac-related death in patients with AMI after the
PTCA procedure.

6

Our results showed that anterior location of
myocardial infarction was associated with a higher
incidence of MACE. The long-term clinical outcomes
were poorer in patients with AW-AMI than NAW-AMI
referred to P-PTCA.
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